Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:

    0.91+0.004 (+0.49%)

    at Fri, May 24, 2024, 4:00PM EDT - U.S.-Märkte öffnen in 4 Stunden 34 Minuten

    Preis in USD

    • Briefkurs 0.00
    • Geld 0.00
    • KGV n. v.
    • 52W-max 1.77
    • 52W-min 0.71
    • Marktkap 159.18Mio.
  1. Find the latest Rigel Pharmaceuticals, Inc. (RIGL) stock quote, history, news and other vital information to help you with your stock trading and investing.

  2. RIGEL PHARMACEUTICALS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Rigel Pharmaceuticals IncShs | 766093 | RIGL | US7665596034

    • Fairer Preis
    • Negative Analystenhaltung seit 12.04.2024
    • Negativer Markttrend seit dem 02.04.2024
    • 766,1K
  3. Rigel develops novel therapies for acute myeloid leukemia and chronic immune thrombocytopenia. Learn about its products REZLIDHIA and TAVALISSE, and its pipeline and clinical trials.

  4. Vor 4 Tagen · News zur RIGEL PHARMACEUTICALS AKTIE und aktueller Realtime-Aktienkurs Earnings call: Rigel Pharmaceuticals Q1 2024 performance and outlook.

    • (3)
  5. Get the latest Rigel Pharmaceuticals Inc (RIGL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  6. 5. März 2024 · SOUTH SAN FRANCISCO, Calif., March 5, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and full year ended December 31, 2023, including sales of TAVALISSE ® (fostamatinib disodium hexahydrate) tablets for the treatment of adults with chronic immune ...

  1. Nutzer haben außerdem gesucht nach